152 related articles for article (PubMed ID: 8983280)
1. Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello GP; Casaretti R; Montella M; Frasci G; Perna M; Comella G
Eur J Cancer; 1996 Sep; 32A(10):1719-26. PubMed ID: 8983280
[TBL] [Abstract][Full Text] [Related]
2. Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group.
Comella P; Crucitta E; De Vita F; De Lucia L; Farris A; Del Gaizo F; Palmeri S; Lannelli A; Mancarella S; Tafuto S; Maiorino L; Buzzi F; De Cataldis G;
Ann Oncol; 2002 Jun; 13(6):866-73. PubMed ID: 12123331
[TBL] [Abstract][Full Text] [Related]
3. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
[TBL] [Abstract][Full Text] [Related]
4. Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracil.
Comella P; Palmieri G; Beneduce G; Casaretti R; Daponte A; Gravina A; Frasci G; Biondi E; Comella G
Oncology; 1996; 53(3):198-203. PubMed ID: 8643221
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
6. Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology Group.
Comella P; Lorusso V; Casaretti R; De Lucia L; Cartení G; Manzione L; Mancarella S; De Lena M; Comella G
Tumori; 1999; 85(6):465-72. PubMed ID: 10774567
[TBL] [Abstract][Full Text] [Related]
7. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.
Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ
Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765
[TBL] [Abstract][Full Text] [Related]
8. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer.
Garufi C; Lévi F; Aschelter AM; Pace R; Giunta S; Nisticò C; Gallà DA; Silecchia GF; Franchi F; Narduzzi C; Terzoli E
Eur J Cancer; 1997 Sep; 33(10):1566-71. PubMed ID: 9389916
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
[TBL] [Abstract][Full Text] [Related]
12. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
Abad A; Garcia P; Gravalos C; Tusquets I; Font A; Perez G; Cortés-Funes H; Fabregat X; Barnadas A; Rosell R
Cancer; 1995 Mar; 75(6):1238-44. PubMed ID: 7882275
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
[TBL] [Abstract][Full Text] [Related]
14. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
Kerr DJ; McArdle CS; Ledermann J; Taylor I; Sherlock DJ; Schlag PM; Buckels J; Mayer D; Cain D; Stephens RJ; ;
Lancet; 2003 Feb; 361(9355):368-73. PubMed ID: 12573372
[TBL] [Abstract][Full Text] [Related]
16. Sequential combination of methotrexate (MTX), 5-fluorouracil (FU), and high-dose folinic acid (FA) in advanced colorectal cancer: double biochemical modulation?
Abad A; Rosell R; Pastor MC; Barnadas A; Carles J; Ribelles N; Oller B; Armengol M; Salva A; Ribas M
Am J Clin Oncol; 1991 Oct; 14(5):393-6. PubMed ID: 1951176
[TBL] [Abstract][Full Text] [Related]
17. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
20. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]